Retatrutide Single Vial
Incretin / GLP-1 · single vial · no minimum order
Retatrutide is available as an individual vial shipped from our UK facility, so a laboratory can take one vial rather than a wholesale box. Every single vial is the same material as the factory-direct range, held in the UK for tracked next-working-day delivery, and supplied strictly for laboratory research.
No minimum order
One vial is a valid order
24 hour UK dispatch
Tracked, working days
99%+ stated purity
Buying at volume instead?
The wholesale format is a multi-vial factory-direct box with a lower per-vial cost and a minimum order quantity. See Retatrutide factory direct.
Retatrutide
About Retatrutide
Retatrutide, also known by its research designation LY3437943, is a triple agonist peptide that represents an advanced approach to metabolic research. This compound is classified as a GGG agonist, referring to its ability to simultaneously target three distinct receptor pathways. The mechanism of action involves activation of GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This triple activation creates a coordinated metabolic response that enhances insulin secretion in a glucose-dependent manner, reduces appetite through central nervous system pathways, and increases energy expenditure via glucagon-mediated mechanisms. The compound also demonstrates effects on glucose metabolism and lipid profile modulation in research models. Studies indicate that retatrutide produces significant weight reduction, improved glucose control, enhanced insulin sensitivity, reduced appetite, and increased energy expenditure in research subjects. The evidence grade is classified as B, reflecting data from Phase III human trials that demonstrate promising metabolic improvements. However, the research literature notes that long-term safety and efficacy data remain limited, with current trials being constrained by duration and participant diversity. The compound's pharmacokinetic profile in research models shows characteristics typical of peptide therapeutics, though specific parameters vary depending on the research protocol and administration route employed in laboratory studies. Research indicates the compound's effects are sustained, making it suitable for studies examining longer-term metabolic adaptations.
Mechanism
Activates GIP, GLP-1 and glucagon receptors. Glucagon component drives additional energy expenditure beyond GLP-1 and GIP.
Reported research findings
- Up to 24.2 percent weight loss at 48 weeks (Phase 2)
- Improved liver fat reduction
- Metabolic rate elevation
Why a single vial
Pilot and method work
A single vial covers assay development, method validation or a short pilot run without committing to a wholesale quantity of Retatrutide.
UK held, fast turnaround
Vials ship from our UK facility on a tracked service, so a study is not waiting on an international consignment or a customs queue.
Same material as the box
Single vials are drawn from the same vetted manufacturing source as the factory-direct range, with the same batch documentation.
Predictable spend
Small laboratories and independent researchers can budget one vial at a time rather than a full minimum order quantity.
Storage and handling
Before reconstitution
Reconstituted 2 to 8 C up to 30 days.
After reconstitution
Reconstituted solution is held refrigerated at 2 to 8°C and used within the window appropriate to the compound. Avoid repeated freeze and thaw cycles.
Reconstitution
Bacteriostatic water is the usual diluent. Our reconstitution calculator works out the diluent volume for a given target concentration.
Documentation
Every vial carries a batch number for traceable laboratory records, and independent verification is encouraged.
See the reconstitution guide and the calculator.
FAQs
Can I order a single vial of Retatrutide without a minimum order?+
Yes. The single-vial range exists precisely so a laboratory can take one vial of Retatrutide rather than a full wholesale box. There is no minimum order quantity on this format.
How quickly does a Retatrutide single vial ship in the UK?+
Single vials are held in our UK facility and dispatched within 24 hours of a cleared payment on working days, on a tracked UK service. Orders placed at the weekend go out on the next working day.
How does the single vial differ from the factory-direct box?+
The compound and the manufacturing source are the same. The factory-direct box is a wholesale multi-vial pack with a minimum order quantity and a lower per-vial cost, while the single vial is one vial from UK stock for small-scale or pilot work.
What purity is stated for Retatrutide?+
99%+ manufacturer-stated purity. Buyers are encouraged to run independent third-party verification, and our testing directory lists laboratories that perform it.
Is this Retatrutide vial for human use?+
No. Every PeptX product, including the single-vial range, is supplied strictly for laboratory research. It is not for human consumption, diagnosis, treatment or any clinical use.
What is Retatrutide?+
Retatrutide (LY3437943) is a triple agonist research peptide that simultaneously activates GLP-1, GIP, and glucagon receptors for metabolic research applications.
How does Retatrutide work?+
Retatrutide works by activating three metabolic receptors: GLP-1, GIP, and glucagon. This triple activation enhances insulin secretion, reduces appetite, and increases energy expenditure in research models.
What is the half-life of Retatrutide?+
Specific half-life data for retatrutide varies depending on the research protocol and administration parameters used in laboratory studies.
How is Retatrutide stored?+
Store lyophilised retatrutide at 2-8°C in a dry environment. Once reconstituted with bacteriostatic water, maintain refrigeration and use within the appropriate stability window for your research.
Other single vials in Incretin / GLP-1
Strictly for laboratory research. Not for human consumption, diagnosis or treatment.